Literature DB >> 16054273

Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model.

Philippe Denoël1, Fabrice Godfroid, Nicole Guiso, Hans Hallander, Jan Poolman.   

Abstract

A significant increase in the incidence of pertussis in adolescents and adults has been observed in vaccinated populations. Concomitantly, emergence of novel pertussis toxin and pertactin types in circulating Bordetella pertussis isolates was noticed. In this study, immunity induced by acellular vaccines against infection due to isolates expressing different pertactin types and fimbriae was monitored in a mouse model. In accordance with previous studies, the effect of a bicomponent DTPa vaccine on bacterial clearance was lower when compared with tri- or pentavalent DTPa vaccines. Whatever the isolates used to infect mice, the tri- or pentavalent DTPa vaccines were both efficacious in inducing immunity that resulted in clearance of infection. These findings suggest that re-emergence of pertussis might not be related to emergence of isolates escaping vaccine protection. The present study reduces potential concerns about acellular vaccine efficacy, but frequent monitoring of protection and surveillance of the evolution of the B. pertussis population remains of particular importance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054273     DOI: 10.1016/j.vaccine.2005.06.021

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice.

Authors:  Kyle Caution; Kacy Yount; Rajendar Deora; Purnima Dubey
Journal:  J Vis Exp       Date:  2019-02-22       Impact factor: 1.355

2.  Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa.

Authors:  Estela M Galván; Manoj Kumar Mohan Nair; Huaiqing Chen; Fabio Del Piero; Dieter M Schifferli
Journal:  Infect Immun       Date:  2010-05-24       Impact factor: 3.441

3.  Immunodominance in mouse and human CD4+ T-cell responses specific for the Bordetella pertussis virulence factor P.69 pertactin.

Authors:  Rachel M Stenger; Martien C M Poelen; Ed E Moret; Betsy Kuipers; Sven C M Bruijns; Peter Hoogerhout; Marcel Hijnen; Audrey J King; Frits R Mooi; Claire J P Boog; Cécile A C M van Els
Journal:  Infect Immun       Date:  2008-11-17       Impact factor: 3.441

4.  Global population structure and evolution of Bordetella pertussis and their relationship with vaccination.

Authors:  Marieke J Bart; Simon R Harris; Abdolreza Advani; Yoshichika Arakawa; Daniela Bottero; Valérie Bouchez; Pamela K Cassiday; Chuen-Sheue Chiang; Tine Dalby; Norman K Fry; María Emilia Gaillard; Marjolein van Gent; Nicole Guiso; Hans O Hallander; Eric T Harvill; Qiushui He; Han G J van der Heide; Kees Heuvelman; Daniela F Hozbor; Kazunari Kamachi; Gennady I Karataev; Ruiting Lan; Anna Lutyńska; Ram P Maharjan; Jussi Mertsola; Tatsuo Miyamura; Sophie Octavia; Andrew Preston; Michael A Quail; Vitali Sintchenko; Paola Stefanelli; M Lucia Tondella; Raymond S W Tsang; Yinghua Xu; Shu-Man Yao; Shumin Zhang; Julian Parkhill; Frits R Mooi
Journal:  mBio       Date:  2014-04-22       Impact factor: 7.867

5.  Preliminary study on the immunogenicity of a newly developed GCC Tdap vaccine and its protection efficacy against Bordetella pertussis in a murine intranasal challenge model.

Authors:  Seung Beom Han; Kyu Ri Kang; Dong Ho Huh; Hee Chul Lee; Soo Young Lee; Jong-Hyun Kim; Jae Kyun Hur; Jin Han Kang
Journal:  Clin Exp Vaccine Res       Date:  2015-01-30

6.  Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in Mice.

Authors:  Kelly L Weaver; Catherine B Blackwood; Alexander M Horspool; Gage M Pyles; Emel Sen-Kilic; Emily M Grayson; Annalisa B Huckaby; William T Witt; Megan A DeJong; M Allison Wolf; F Heath Damron; Mariette Barbier
Journal:  Front Immunol       Date:  2022-02-08       Impact factor: 7.561

7.  Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003.

Authors:  Shane Byrne; Andrew T Slack
Journal:  BMC Infect Dis       Date:  2006-03-16       Impact factor: 3.090

8.  Trypanosomiasis-induced B cell apoptosis results in loss of protective anti-parasite antibody responses and abolishment of vaccine-induced memory responses.

Authors:  Magdalena Radwanska; Patrick Guirnalda; Carl De Trez; Bernard Ryffel; Samuel Black; Stefan Magez
Journal:  PLoS Pathog       Date:  2008-05-30       Impact factor: 6.823

9.  New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates.

Authors:  Valérie Bouchez; Nicolas Hegerle; Francesco Strati; Elisabeth Njamkepo; Nicole Guiso
Journal:  Vaccines (Basel)       Date:  2015-09-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.